Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic predisposition and treatment-related leukemia.

Medical and pediatric oncology - 1 May 2001

Perentesis J P

Abstract excerpt

Treatment-related leukemias are one of the most devastating late complications of cancer therapy. Patients with rare cancer predisposition syndromes including neurofibromatosis type 1 and inherited p53 mutations are at an increased risk for this complication. Other patients may have increased sus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CBS gene
Share to MTHFR gene
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to Leukemia

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 11340609
DOI: 10.1002/mpo.1127

Genes

CBS
MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11340609-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic predisposition and treatment-related leukemia.PMID 11340609Read ↗

Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.Semantic proximity Read ↗

Fanconi anemia gene variants in therapy-related myeloid neoplasmsSemantic proximity Read ↗

Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.Semantic proximity Read ↗

Influence of DNA damage and repair upon the risk of treatment related leukemia.Semantic proximity Read ↗

The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes.Semantic proximity Read ↗

DNA Damage and Repair in Human Cancer: Molecular Mechanisms and Contribution to Therapy-Related LeukemiasSemantic proximity Read ↗

Genetic susceptibility to iatrogenic malignancy.Semantic proximity Read ↗

CYP1A1*2B (Val) allele is overrepresented in a subgroup of acute myeloid leukemia patients with poor-risk karyotype associated with NRAS mutation, but not associated with FLT3 internal tandem duplication.Semantic proximity Read ↗

Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression.Semantic proximity Read ↗

Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk.Semantic proximity Read ↗

CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility.Semantic proximity Read ↗

Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.